↓ Skip to main content

Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.

Overview of attention for article published in Cochrane database of systematic reviews, June 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.
Published in
Cochrane database of systematic reviews, June 2012
DOI 10.1002/14651858.cd002052.pub2
Pubmed ID
Authors

Ng E, Taddio A, Ohlsson A

Abstract

Proper sedation for neonates undergoing uncomfortable procedures may reduce stress and avoid complications. Midazolam is a short-acting benzodiazepine that is increasingly used in neonatal intensive care units (NICU). However, its effectiveness as a sedative in neonates has not been systematically evaluated.

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Norway 1 2%
Unknown 46 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 17%
Researcher 8 17%
Student > Bachelor 7 15%
Student > Ph. D. Student 7 15%
Other 4 8%
Other 10 21%
Unknown 4 8%
Readers by discipline Count As %
Medicine and Dentistry 25 52%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Agricultural and Biological Sciences 3 6%
Psychology 3 6%
Neuroscience 2 4%
Other 3 6%
Unknown 7 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2012.
All research outputs
#1,389,285
of 12,101,174 outputs
Outputs from Cochrane database of systematic reviews
#2,996
of 7,978 outputs
Outputs of similar age
#13,205
of 113,129 outputs
Outputs of similar age from Cochrane database of systematic reviews
#35
of 104 outputs
Altmetric has tracked 12,101,174 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 113,129 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.